NBTX Going LongNASDAQ:NBTX "Long" setup
D1 Oversold / Real Value OS / MFI OS
H1 CS Reversal Conf
Wait for trend line breakout to add long
Price Target on the chart
Nanobiotix SA
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−68.13 M EUR
−11.61 M EUR
46.77 M
About Nanobiotix SA
Sector
Industry
CEO
Laurent Lévy
Website
Headquarters
Paris
Founded
2003
Identifiers
2
ISINFR0011341205
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
Related stocks
$NANO #nanobitix lots of upside!$NANO #nanobitix chart is looking great! The declining trendline is broken and the resistance @ 7.20-7.25 zone is put under pressure right now #long
$NANO #nanobiotix recently did an offering, full pipeline!$NANO #nanobiotix Nice charts, the declining trendline needs to be broken to get an 100% BUY signal. On watch for now
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
EMUSC.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR acc- CapitalisationWeight
0.12%
Market value
839.51 K
USD
EMUSCD.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR Ukdis- DistributionWeight
0.12%
Market value
839.51 K
USD
UEFD
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR dis- DistributionWeight
0.12%
Market value
839.51 K
USD
Explore more ETFs
Frequently Asked Questions
The current price of 5NR is 19.90 EUR — it has increased by 5.18% in the past 24 hours. Watch Nanobiotix SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Nanobiotix SA stocks are traded under the ticker 5NR.
5NR stock has risen by 5.29% compared to the previous week, the month change is a 13.15% rise, over the last year Nanobiotix SA has showed a 537.82% increase.
We've gathered analysts' opinions on Nanobiotix SA future price: according to them, 5NR price has a max estimate of 28.00 EUR and a min estimate of 3.33 EUR. Watch 5NR chart and read a more detailed Nanobiotix SA stock forecast: see what analysts think of Nanobiotix SA and suggest that you do with its stocks.
5NR stock is 6.17% volatile and has beta coefficient of 1.23. Track Nanobiotix SA stock price on the chart and check out the list of the most volatile stocks — is Nanobiotix SA there?
Today Nanobiotix SA has the market capitalization of 948.23 M, it has decreased by −2.99% over the last week.
Yes, you can track Nanobiotix SA financials in yearly and quarterly reports right on TradingView.
Nanobiotix SA is going to release the next earnings report on Apr 28, 2026. Keep track of upcoming events with our Earnings Calendar.
5NR earnings for the last half-year are −0.11 EUR per share, whereas the estimation was −0.21 EUR, resulting in a 47.62% surprise. The estimated earnings for the next half-year are 0.01 EUR per share. See more details about Nanobiotix SA earnings.
Nanobiotix SA revenue for the last half-year amounts to 26.60 M EUR, despite the estimated figure of 20.35 M EUR. In the next half-year revenue is expected to reach 25.40 M EUR.
5NR net income for the last half-year is −5.38 M EUR, while the previous report showed −21.87 M EUR of net income which accounts for 75.39% change. Track more Nanobiotix SA financial stats to get the full picture.
No, 5NR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2025, the company has 108 employees. See our rating of the largest employees — is Nanobiotix SA on this list?
Like other stocks, 5NR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nanobiotix SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nanobiotix SA technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nanobiotix SA stock shows the buy signal. See more of Nanobiotix SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.